← Back to Search

Stent System

Next Generation Neuroform Stent System for Brain Aneurysm (ATLAS Trial)

N/A

Waitlist Available

Led By Brian Jankowitz, MD

Research Sponsored by Stryker Neurovascular

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 12 month post index procedure

Awards & highlights

ATLAS Trial Summary

This trial will test how effective and safe a new type of stent is for use with metal coils to block off blood vessels.

Eligible Conditions

Brain Aneurysm

ATLAS Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 12 month post index procedure

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~12 month post index procedure

This trial's timeline: 3 weeks for screening, Varies for treatment, and 12 month post index procedure for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Aneurysm Occlusion of the Treated Target Lesion on 12 Month Angiography

Stroke or Death

Secondary outcome measures

The Percent of Subjects Experiencing One or More Serious Adverse Events (SAEs) Through 12 Months

ATLAS Trial Design

1Treatment groups

Experimental Treatment

Group I: Next Generation Neuroform Stent SystemExperimental Treatment1 Intervention

The Next Generation Stent System is a self-expanding, open cell, nitinol stent designed to provide support of the coil mass within the aneurysm and minimize stent deflection.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Next Generation Neuroform Stent System

2015

N/A

~300

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Stryker NeurovascularLead Sponsor

34 Previous Clinical Trials

11,941 Total Patients Enrolled

Brian Jankowitz, MDPrincipal InvestigatorCooper University Health Center

3 Previous Clinical Trials

291 Total Patients Enrolled

Osama Zaidat, MDPrincipal InvestigatorMercy Health - St. Vincent Medical Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Recent research and studies

Journal of NeuroInterventional SurgeryJournal

Pivotal Trial of the Neuroform Atlas Stent for Treatment of Posterior Circulation Aneurysms: One-year Outcomes

Jankowitz, Brian T, Ashutosh P Jadhav, Bradley Gross, Tudor G Jovin, Abdulnasser A Alhajeri, Justin F Fraser, Ricardo A Hanel, et al.. 2021. “Pivotal Trial of the Neuroform Atlas Stent for Treatment of Posterior Circulation Aneurysms: One-year Outcomes”. Journal of Neurointerventional Surgery. BMJ. doi:10.1136/neurintsurg-2020-017115.

StrokeJournal

Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms

Zaidat, Osama O., Ricardo A. Hanel, Eric A. Sauvageau, Amin Aghaebrahim, Eugene Lin, Ashutosh P. Jadhav, Tudor G. Jovin, et al.. 2020. “Pivotal Trial of the Neuroform Atlas Stent for Treatment of Anterior Circulation Aneurysms”. Stroke. Ovid Technologies (Wolters Kluwer Health). doi:10.1161/strokeaha.119.028418.

Journal of NeuroInterventional SurgeryJournal

Pivotal Trial of the Neuroform Atlas Stent for Treatment of Posterior Circulation Aneurysms: One-year Outcomes

clinicaltrials.govStudy

Neuroform Atlas Stent System Study

2015. "Neuroform Atlas Stent System Study". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02340585.

~30 spots leftby Apr 2025

Unbiased ResultsWe believe in providing patients with all the options.

Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.

Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.